SciMatic Home SciMatic
  • Journals
  • Thesis Rep
  • Docs
  • Products
    SciMatic.net Journament Journal Manager Subjects Thesis ImProofer Research Groups Letter Pad Conferences
  • Services
  • About
    SciMatic Blog Team Earn With Us Join Us Contact Us
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文
Login

Keyword Connections

sustained virologic response
Journals
0
No Journal Connected
Research Groups
0
No Research Group Connected
Bibliographies
9
1 Hepatitis C Virus-Infected Patients Receiving Opioid Substitution Therapy Experience Improvement in Patient-Reported Outcomes Following Treatment With Interferon-Free Regimens
2 Directly observed therapy of chronic hepatitis C with ledipasvir/sofosbuvir in people who inject drugs at risk of nonadherence to direct-acting antivirals
3 Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis
4 Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials
5 Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial
6 Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis
7 Real-world effectiveness and predictors of sustained virological response with all-oral therapy in 21,242 hepatitis C genotype-1 patients
8 Resistance analysis in patients with genotype 1-6 HCV infection treated with sofosbuvir/velpatasvir in the phase III studies
9 Understanding real-world adherence in the directly acting antiviral era: A prospective evaluation of adherence among people with a history of drug use at a community-based program in Toronto, Canada
SciMatic
SciMatic on Your Phone Track your articles, view certificates, and stay updated — anywhere, anytime.
Google Play
About
  • About
  • Team
  • Join Us
  • Privacy and Security
  • KVKK Aydınlatma Metni
  • Cookie settings
  • Terms of Sale
  • Blacklisted Persons
  • Delete Account
  • Documentations
Services
  • Thesis Manager
  • Semester Manager
  • Journals
  • Conferences
  • Journament Indexings
  • API
Legal
SciMatic © 2014–2026 ZincirX Inc.

All Rights Reserved!

Creative Commons License
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

SciBot
AI Assistant
Hi! I'm SciBot, your SciMatic assistant. I can help with manuscript submissions, journal info, and navigating the platform. How can I help?

How we process your personal data: Privacy Notice. In Türkiye: KVKK Aydınlatma Metni.

Contact Us
Login Required

Register/Login first to send a message

Login

Cookies

We use strictly necessary cookies to run the site and keep you signed in. With your permission we would also use analytics (Google Analytics, Google Tag Manager, Yandex Metrica) to see how the site is used, and Google AdSense to show ads. They stay off unless you accept, and you can change your mind at any time. How we use cookies · KVKK notice (Türkiye)

Cookie settings

Your session, form security (XSRF) and this choice. The site does not work without them.
Google Analytics 4 and Google Tag Manager (Google LLC, USA; the _ga and _ga_* cookies, up to 2 years) and, on some pages, Yandex Metrica (Yandex LLC, Russia; _ym_uid and _ym_d up to 1 year, and other _ym cookies): measure which pages are visited and what is clicked.
Google AdSense (Google LLC, USA): shows and measures ads; the __gads, __gpi and __eoi cookies are kept for up to 13 months, and Google may also use ad cookies on its own domains.